VOGLIDIN GM 3.3

VOGLIDIN GM 3 contains Glimepiride 2 mg + Metformin (SR) 500 mg + Voglibose 0.3 mg, a triple-combination therapy for effective type 2 diabetes control. Glimepiride stimulates insulin release, Metformin improves insulin sensitivity and reduces liver glucose production, while Voglibose slows carbohydrate absorption after meals. This combination helps manage fasting and post-meal blood sugar levels and supports better long-term glycemic balance.